HCW Biologics Inc. Contracts & Agreements
37 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (5)
- Human Resources (8)
- Intellectual Property (1)
- Real Estate (1)
- Uncategorized (4)
- Form of Common Stock Purchase Warrant between the Company and Holder (Filed With SEC on November 20, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant between the Company and Holder (Filed With SEC on November 20, 2024)
- Placement Agency Agreement, dated November 18, 2024, between the Company and Maxim Group LLC (Filed With SEC on November 20, 2024)
- Securities Purchase Agreement, dated November 18, 2024, between the Company and Purchaser (Filed With SEC on November 20, 2024)
- Form of First Amendment to the Amended and Restated Senior Secured Note Purchase Agreement, dated September 30, 2024, by and between the Company and Purchaser parties thereto (Filed With SEC on November 14, 2024)
- Settlement Agreement and Release, dated July 13, 2024, by and between the Company and Altor BioScience, LLC, NantCell, Inc., and ImmunityBio, Inc (Filed With SEC on November 14, 2024)
- Form of Amended and Restated Senior Secured Note Purchase Agreement, dated July 2, 2024, by and between the Company and the Purchaser party thereto (Filed With SEC on August 14, 2024)
- Form of Senior Secured Promissory Note by and between the Company and the Holder party thereof (Filed With SEC on August 14, 2024)
- Form of Amended and Restated Pledge Agreement, dated July 2, 2024, by and among the Company, Escrow Agent and Noteholder parties thereto (Filed With SEC on August 14, 2024)
- Form of Escrow Agreement, dated July 2, 2024, by and among the Company, Escrow Agent and Noteholder parties thereto (Filed With SEC on August 14, 2024)
- Senior Secured Note Purchase Agreement, dated March 28, 2024, by and between the Company and the Purchaser party thereto (Filed With SEC on May 15, 2024)
- Form of Subscription Agreement, dated February 20, 2024, by and between the Company and the Subscribers party thereto (Filed With SEC on May 15, 2024)
- Form of Senior Secured Note Purchase Agreement, dated March 28, 2024, by and between the Company and the Purchaser party thereto (Filed With SEC on April 1, 2024)
- Form of Senior Secured Promissory Note, dated March 28, 2024, by and between the Company and the Holder party thereof (Filed With SEC on April 1, 2024)
- Form of Pledge Agreement, dated March 28, 2024, by and between the Company, Escrow Agent and Noteholder party thereto (Filed With SEC on April 1, 2024)
- Form of Escrow Agreement, dated March 28, 2024, by and between the Company, Escrow Agent and Noteholder party thereto (Filed With SEC on April 1, 2024)
- Form of Common Stock Subscription Agreement (Filed With SEC on February 22, 2024)
- Loan Agreement by and between HCW Biologics Inc. and Cogent Bank, dated August 15, 2022 (Filed With SEC on November 7, 2022)
- Mortgage and Security Agreement by and between HCW Biologics Inc. and Cogent Bank, dated August 15, 2022 (Filed With SEC on November 7, 2022)
- Purchase and Sale Agreement, by and between HCW Biologics Inc. and Wai 3300Corporate Way, LLC, dated May 27, 2022 (Filed With SEC on August 12, 2022)
- Description of Securities (Filed With SEC on March 29, 2022)
- Form of Underwriting Agreement (Filed With SEC on July 9, 2021)
- 2021 Equity Incentive Plan and forms of agreement thereunder (Filed With SEC on July 7, 2021)
- Employment Agreement between Peter Rhode and the Registrant, dated July 6, 2021 (Filed With SEC on July 7, 2021)
- Master Services Agreement, dated March 14, 2019 between the Registrant and EirGenix, Inc (Filed With SEC on July 7, 2021)
- Employment Agreement between Dr. Hing C. Wong and the Registrant dated June 18, 2021 (Filed With SEC on July 7, 2021)
- Specimen Stock Certificate (Filed With SEC on June 15, 2021)
- Form of Indemnification Agreement between the Registrant and each of its officers and directors (Filed With SEC on June 15, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on June 15, 2021)
- Executive Incentive Bonus Plan (Filed With SEC on June 15, 2021)
- Amended and Restated Investor Rights Agreement by and among Registrant and certain holders of its capital stock dated September 30, 2020 (Filed With SEC on May 26, 2021)
- 2019 Equity Incentive Plan, as amended, and forms of agreement thereunder (Filed With SEC on May 26, 2021)
- First Amendment to 2019 Equity Incentive Plan (Filed With SEC on May 26, 2021)
- Offer Letter between Peter Rhode and the Registrant, dated April 30, 2019 (Filed With SEC on May 26, 2021)
- Employment Agreement between Rebecca Byam and the Registrant, dated October 9, 2019 (Filed With SEC on May 26, 2021)
- Exclusive License Agreement, dated December 24, 2020 between the Registrant and Wugen, Inc (Filed With SEC on May 26, 2021)
- Master Services Agreement, dated March 14, 2019 between the Registrant and EirGenix, Inc (Filed With SEC on May 26, 2021)
